Simvastatin suppresses LPS-induced Akt phosphorylation in the human monocyte cell line THP-1

Journal of Surgical Research

Volumn 116, Issue 1, 2004, Pages 116-120

  Patel, Tushar R ^a   Corbett, Siobhan A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Akt; LPS; Simvastatin; Statin; THP 1

Indexed keywords

ENZYME ANTIBODY; LIPOPOLYSACCHARIDE; PHALLOIDIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN KINASE B ANTIBODY; PROTEIN KINASE B; RAC PROTEIN; SIMVASTATIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL LYSATE; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CONTROLLED STUDY; CYTOSKELETON; DENSITOMETRY; DOWN REGULATION; DRUG MECHANISM; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL; LEUKOCYTE ADHERENCE; MONOCYTIC LEUKEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; UPREGULATION;

EID: 0347090640     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.07.006     Document Type: Article

References (11)

1. Hall A. Rho GTPases and the actin cytoskeleton. Science. 279:1998;509.
2. Burridge K. Crosstalk between Rac and Rho. Science. 283:1999;2028.
3. Bannerman D.D., Goldblum S.E. Direct effects of endotoxin on the endothelium Barrier function and injury . Lab. Invest. 79:1999;1181.
4. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., Knaus U.G. Toll-like receptor 2-mediated NF- κB activation requires a rac1-dependent pathway. Nat. Immunol. 1:2000;533.
5. Shiojima I., Walsh K. Role of Akt Signaling in vascular homeostasis and angiogenesis. Circ. Res. 90:2002;1243.
6. Takemato M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arteriosclerosis Thrombosis Vasc. Biol. 21:2001;1712.
7. Ridley A.J. Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett. 498:2001;168.
8. Laufs U., Liao J.K. Direct vascular effects of HMG-CoA reductase inhibitors. TCM. 10:2000;143.
9. Horiuchi M., Cui T.X., Li Z., Li J.M., Nakagami H., Iwai M. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type I receptor blocker, valsartan, on vascular neointimal formation. Circulation. 107:2003;106.
10. Vecchione C., Brandes R.P. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ. Res. 91:2002;173.
11. Laufs U., Kilter H., Konkol C., Wassmann S., Bohm M., Nickenig G. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovascular Res. 53:2002;911.